trial · primary record
DB-1311/BNT324
Solid Tumors
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 750 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Part 1: Number of participants with Dose Limiting Toxicities (DLTs). |
| Registry ID | NCT06953089 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:38.605Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06953089
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.